Mark Baer

1.5k total citations
23 papers, 1.3k citations indexed

About

Mark Baer is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Mark Baer has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Mark Baer's work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (6 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Mark Baer is often cited by papers focused on Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (6 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Mark Baer collaborates with scholars based in United States, Australia and France. Mark Baer's co-authors include Peter F. Johnson, Richard C. Schwartz, Simon C. Williams, Allan Dillner, Christopher Bebbington, Geoffrey Yarranton, Sergei A. Nedospasov, Ulrich Siebenlist, Howard A. Young and Estefanı́a Claudio and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Mark Baer

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Baer United States 15 582 485 277 222 132 23 1.3k
Kristen Page United States 26 555 1.0× 524 1.1× 137 0.5× 164 0.7× 97 0.7× 39 1.7k
Jason S Rawlings United States 8 843 1.4× 609 1.3× 274 1.0× 535 2.4× 124 0.9× 13 1.9k
Jane Guo United States 19 768 1.3× 798 1.6× 365 1.3× 320 1.4× 146 1.1× 32 1.9k
David L. Caudell United States 23 568 1.0× 247 0.5× 186 0.7× 178 0.8× 135 1.0× 66 1.3k
Vito Ruggiero Italy 14 415 0.7× 821 1.7× 197 0.7× 201 0.9× 64 0.5× 29 1.3k
Glen M. Scholz Australia 23 806 1.4× 855 1.8× 249 0.9× 248 1.1× 72 0.5× 58 1.8k
Arūnas Kazlauskas Lithuania 19 827 1.4× 236 0.5× 374 1.4× 127 0.6× 80 0.6× 34 1.6k
Maya Kozlowski Canada 21 914 1.6× 976 2.0× 183 0.7× 335 1.5× 74 0.6× 35 2.1k
Andris Avots Germany 21 1.0k 1.8× 913 1.9× 328 1.2× 285 1.3× 44 0.3× 36 1.8k
G. Duke Virca United States 22 830 1.4× 946 2.0× 455 1.6× 337 1.5× 199 1.5× 29 2.1k

Countries citing papers authored by Mark Baer

Since Specialization
Citations

This map shows the geographic impact of Mark Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baer more than expected).

Fields of papers citing papers by Mark Baer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baer. The network helps show where Mark Baer may publish in the future.

Co-authorship network of co-authors of Mark Baer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Baer. A scholar is included among the top collaborators of Mark Baer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Baer. Mark Baer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vail, Mary E., Carmel Murone, Linda Hii, et al.. (2014). Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment. Cancer Research. 74(16). 4470–4481. 67 indexed citations
2.
Legrand, Fanny, Nenad Tomas̆ević, Olga Šimáková, et al.. (2014). The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders. Journal of Allergy and Clinical Immunology. 133(5). 1439–1447.e8. 52 indexed citations
3.
Tomas̆ević, Nenad, Kenneth R. Luehrsen, Mark Baer, et al.. (2014). A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity. Growth Factors. 32(6). 223–235. 10 indexed citations
4.
Padron, Eric, Jeffrey S. Painter, Sateesh Kunigal, et al.. (2013). GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 121(25). 5068–5077. 108 indexed citations
5.
6.
Padron, Eric, Jeffrey S. Painter, Adam W. Mailloux, et al.. (2011). GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia. Blood. 118(21). 1713–1713. 2 indexed citations
7.
Kellar, Robert S., Elizabeth Juneman, Nicholle M. Johnson, et al.. (2011). Antibody to Granulocyte Macrophage Colony–stimulating Factor Reduces the Number of Activated Tissue Macrophages and Improves Left Ventricular Function After Myocardial Infarction in a Rat Coronary Artery Ligation Model. Journal of Cardiovascular Pharmacology. 57(5). 568–574. 10 indexed citations
8.
9.
Baer, Mark, Teiji Sawa, Peter J. Flynn, et al.. (2008). An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity. Infection and Immunity. 77(3). 1083–1090. 94 indexed citations
10.
Papalia, Giuseppe A., et al.. (2006). High-resolution characterization of antibody fragment/antigen interactions using Biacore T100. Analytical Biochemistry. 359(1). 112–119. 36 indexed citations
11.
Baer, Mark, Howard A. Young, Estefanı́a Claudio, et al.. (2004). BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages. Journal of Biological Chemistry. 279(48). 49995–50003. 171 indexed citations
12.
Baer, Mark, et al.. (2002). Regulation of CCAAT/Enhancer-binding Protein (C/EBP) Activator Proteins by Heterodimerization with C/EBPγ (Ig/EBP). Journal of Biological Chemistry. 277(26). 23563–23572. 59 indexed citations
13.
Tian, Qiang, Mark Baer, Chauncey J. Spooner, et al.. (2000). The C/EBP bZIP Domain Can Mediate Lipopolysaccharide Induction of the Proinflammatory Cytokines Interleukin-6 and Monocyte Chemoattractant Protein-1. Journal of Biological Chemistry. 275(21). 16373–16381. 86 indexed citations
14.
Baer, Mark & Peter F. Johnson. (2000). Generation of Truncated C/EBPβ Isoforms by in VitroProteolysis. Journal of Biological Chemistry. 275(34). 26582–26590. 66 indexed citations
15.
Baer, Mark, Simon C. Williams, Allan Dillner, Richard C. Schwartz, & Peter F. Johnson. (1998). Autocrine Signals Control CCAAT/Enhancer Binding Protein β Expression, Localization, and Activity in Macrophages. Blood. 92(11). 4353–4365. 44 indexed citations
16.
Baer, Mark, et al.. (1998). Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50. Molecular and Cellular Biology. 18(10). 5678–5689. 161 indexed citations
17.
Baer, Mark, et al.. (1998). Redundancy of C/EBPα, -β, and -δ in Supporting the Lipopolysaccharide-Induced Transcription of IL-6 and Monocyte Chemoattractant Protein-1. The Journal of Immunology. 160(5). 2334–2342. 74 indexed citations
18.
Lee, Ying‐Hue, Simon C. Williams, Mark Baer, et al.. (1997). The Ability of C/EBPβ but Not C/EBPα To Synergize with an Sp1 Protein Is Specified by the Leucine Zipper and Activation Domain. Molecular and Cellular Biology. 17(4). 2038–2047. 122 indexed citations
19.
Baer, Mark & Gwendolyn B. Sancar. (1993). The role of conserved amino acids in substrate binding and discrimination by photolyase. Journal of Biological Chemistry. 268(22). 16717–16724. 20 indexed citations
20.
Baer, Mark & Gwendolyn B. Sancar. (1989). Photolyases from Saccharomyces cerevisiae and Escherichia coli Recognize Common Binding Determinants in DNA Containing Pyrimidine Dimers. Molecular and Cellular Biology. 9(11). 4777–4788. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen Page Breakdown of academic impact, for papers by Jason S Rawlings Breakdown of academic impact, for papers by Jane Guo Breakdown of academic impact, for papers by David L. Caudell Breakdown of academic impact, for papers by Vito Ruggiero Breakdown of academic impact, for papers by Glen M. Scholz Breakdown of academic impact, for papers by Arūnas Kazlauskas Breakdown of academic impact, for papers by Maya Kozlowski Breakdown of academic impact, for papers by Andris Avots Breakdown of academic impact, for papers by G. Duke Virca
Rankless by CCL
2026